Advertisement
IDNA or IXJ or VHT
Which ETF would AI Choose? iShares Genomics Immunology and Healthcare ETF (IDNA) vs. iShares Global Healthcare ETF (IXJ) vs. Vanguard Health Care ETF (VHT)
Key Takeaways
- IDNA offers a concentrated, thematic approach focused on genomics, immunology, and bioengineering with higher expense ratio and fewer holdings.
- IXJ provides broad global healthcare sector exposure with moderate concentration and a global index methodology.
- VHT delivers the broadest diversification within U.S. healthcare through a low-cost, market-cap-weighted index with hundreds of holdings.
- Expense ratios vary significantly, with VHT at the lowest cost and IDNA at the highest due to its specialized thematic strategy.
- Structural differences create distinct risk profiles: IDNA carries higher concentration risk, while VHT emphasizes broad market representation.
- Positioning depends on investor preference for thematic innovation exposure versus diversified sector or geographic breadth.
Introduction
These three exchange-traded funds (ETFs) target the healthcare sector but employ different strategies. IDNA focuses on a narrow thematic slice of genomics and immunology. IXJ tracks a global healthcare index for international diversification. VHT offers comprehensive U.S. healthcare exposure. Investors comparing them evaluate trade-offs between specialized innovation themes, global breadth, and broad domestic diversification in the current market environment.
iShares Genomics Immunology and Healthcare ETF (IDNA) Overview
IDNA seeks to track the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund holds approximately 50 securities and emphasizes companies benefiting from advancements in genomics, immunology, and bioengineering. Top holdings typically include firms such as Moderna and Twist Bioscience. Sector allocation centers on healthcare innovation subsectors. The expense ratio stands at 0.47%. It operates as a passive, rules-based thematic ETF with physical replication and periodic rebalancing aligned to the underlying index.
iShares Global Healthcare ETF (IXJ) Overview
IXJ tracks the S&P Global 1200 Health Care Sector Capped Index. The ETF maintains around 110 holdings across global markets. Top positions often feature large pharmaceutical and biotech companies such as Eli Lilly and Johnson & Johnson. Allocation spans pharmaceuticals, biotechnology, and medical devices worldwide. The expense ratio is 0.38%. It functions as a passive sector ETF with market-cap weighting and periodic index rebalancing to reflect global healthcare sector composition.
Vanguard Health Care ETF (VHT) Overview
VHT follows the MSCI US Investable Market Health Care 25/50 Index. The fund contains over 400 holdings, providing extensive coverage of U.S. healthcare companies across market capitalizations. Top holdings commonly include Eli Lilly, Johnson & Johnson, and AbbVie. Sector allocation covers pharmaceuticals, biotechnology, healthcare equipment, and services. The expense ratio is 0.09%. It employs a passive indexing approach with full replication where possible and regular rebalancing to match the benchmark.
Industry and Thematic Landscape
The healthcare sector faces ongoing influences from innovation in biotechnology, regulatory developments, aging demographics, and capital allocation toward life sciences. Macroeconomic factors such as interest rate environments and earnings growth in major pharmaceutical firms shape flows. Geopolitical considerations affect global supply chains for medical products. Thematic areas like genomics attract targeted investment, while broad sector funds capture diversified exposure across established players and emerging opportunities.
Performance and Positioning Comparison
In recent market cycles, IDNA has shown greater sensitivity to innovation-driven themes, resulting in higher volatility compared with the broader sector funds. IXJ reflects global healthcare dynamics, including international currency and regulatory influences. VHT demonstrates more stable trend consistency due to its wide diversification across U.S. healthcare constituents. Performance differentials arise from concentration levels, geographic scope, and expense structures rather than short-term price fluctuations.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.
Tickeron AI Verdict
Tickeron’s AI would likely favor VHT currently due to its superior cost efficiency, extensive diversification across hundreds of holdings, and balanced risk-adjusted positioning within the U.S. healthcare sector. The low expense ratio and broad index construction support more stable exposure compared with the higher-cost thematic concentration of IDNA or the global scope of IXJ.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
IDNA in +4.25% Uptrend, advancing for three consecutive days on October 21, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IDNA advanced for three days, in 238 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on IDNA as a result. In 75 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 167 of 197 cases where IDNA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
Bearish Trend Analysis
The 10-day RSI Indicator for IDNA moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 18 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Moving Average Convergence Divergence Histogram (MACD) for IDNA turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 42 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
IDNA broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
IXJ in upward trend: 10-day moving average moved above 50-day moving average on October 19, 2026
The 10-day moving average for IXJ crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on IXJ as a result. In 68 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for IXJ just turned positive on October 12, 2026. Looking at past instances where IXJ's MACD turned positive, the stock continued to rise in 41 of 49 cases over the following month. The odds of a continued upward trend are 84%.
IXJ moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where IXJ advanced for three days, in 260 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
IXJ broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IXJ entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
VHT in downward trend: price may decline as a result of having broken its higher Bollinger Band on October 20, 2026
VHT broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 42 similar instances where the stock broke above the upper band. In 37 of the 42 cases the stock fell afterwards. This puts the odds of success at 88%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VHT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for VHT entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on VHT as a result. In 70 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for VHT just turned positive on October 12, 2026. Looking at past instances where VHT's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.
VHT moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for VHT crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Following a +4.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where VHT advanced for three days, in 255 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
| IDNA | IXJ | VHT | |
|---|---|---|---|
| RSI ODDS (%) | 1 day ago 82% | 1 day ago 83% | 1 day ago 81% |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 76% | 1 day ago 75% |
| Momentum ODDS (%) | 1 day ago 84% | 1 day ago 74% | 1 day ago 80% |
| MACD ODDS (%) | 1 day ago 81% | 1 day ago 84% | 1 day ago 80% |
| TrendWeek ODDS (%) | 1 day ago 88% | 1 day ago 79% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 89% | 1 day ago 80% | 1 day ago 81% |
| Advances ODDS (%) | 2 days ago 85% | 8 days ago 80% | 8 days ago 81% |
| Declines ODDS (%) | 10 days ago 87% | 4 days ago 77% | 4 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 86% | 1 day ago 79% | 1 day ago 88% |
| Aroon ODDS (%) | 1 day ago 85% | 1 day ago 89% | 1 day ago 88% |
Advertisement
IXJ and
Correlation & Price change
A.I.dvisor indicates that over the last year, IXJ has been closely correlated with LLY. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if IXJ jumps, then LLY could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SFLO | 40.16 | 0.62 | +1.57% |
| VictoryShares Small Cap Free Cash Flow ETF (SFLO) | |||
| CAMX | 34.83 | N/A | N/A |
| Cambiar Aggressive Value ETF (CAMX) | |||
| DFUS | 83.13 | -1.03 | -1.22% |
| Dimensional U.S. Equity Market ETF (DFUS) | |||
| GUSH | 48.35 | -1.13 | -2.28% |
| Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF (GUSH) | |||
| FUTG | 3.10 | -0.41 | -11.62% |
| Leverage Shares 2x Long FUTU Daily ETF (FUTG) | |||